GILEAD SCIENCES PTY LIMITED

LEVEL 28 385 BOURKE STREET, Melbourne, Victoria, Australia

Also known as:

gilead sciences pty ltd

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

100.0%

Trial Status Distribution

Recruiting

100.0%

Clinical Trials

Trials sponsored by this organization (1)

Study of Acquired Viral Mutations in Chronic Hepatitis B Patients on Antihepadnaviral Therapy

Not Applicable

Recruiting

observational

Jul 2007800 participants

Approvals

Approvals by Agency

TGA

Therapeutic Goods Administration

Approvals

Recent Approvals

SUNLENCA lenacapavir (as sodium) 300 mg film coated tablet bottle (468505)

TGA

2025-07-11

SUNLENCA lenacapavir (as sodium) 300 mg film coated tablet bottle (468505)

TGA

2025-07-11

HEPCLUDEX bulevirtide (as acetate) 2 mg powder for injection vial (407179)

TGA

2024-07-30

HEPCLUDEX bulevirtide (as acetate) 2 mg powder for injection vial (407179)

TGA

2024-07-30

SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial (386895)

TGA

2023-03-27

SUNLENCA lenacapavir (as sodium) 300 mg film coated tablet blister pack (392350)

TGA

2023-03-27

SUNLENCA lenacapavir (as sodium) 300 mg film coated tablet blister pack (392350)

TGA

2023-03-27

SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial (386895)

TGA

2023-03-27

Cellular Therapies - T Cells - Axicabtagene ciloleucel, cryopreserved - T - Yescarta - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag (400895)

TGA

2022-12-12

Cellular Therapies - T Cells - Axicabtagene ciloleucel, cryopreserved - T - Yescarta - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag (400895)

TGA

2022-12-12

News

No news articles found

Back to Organizations